Kite Pharma
North America, California, United States, Los Angeles
Description
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.
Investor Profile
Kite Pharma has made 12 investments, with 0 in the past 12 months and 17% as lead.
Stage Focus
- Post Ipo Equity (25%)
- Series B (17%)
- Series A (17%)
- Series C (17%)
- Corporate Round (17%)
- Series Unknown (8%)
Country Focus
- United States (75%)
- The Netherlands (8%)
- China (8%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- France (8%)
Industry Focus
- Biotechnology
- Therapeutics
- Pharmaceutical
- Health Care
- Life Science
- Medical
- Biopharma
- Genetics
- Oncology
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
